Status:

UNKNOWN

Low-Intensity Extracorporeal Shockwave Therapy for Penile Rehabilitation in Post-Radical Prostatectomy Patients

Lead Sponsor:

Hospital Pengajar Universiti Putra Malaysia

Conditions:

Erectile Dysfunction Following Radical Prostatectomy

Eligibility:

MALE

40-75 years

Phase:

NA

Brief Summary

Radical prostatectomy (RP) is one of the curative treatment modalities for localized or locally advanced prostate cancer. Urinary incontinence and erectile dysfunction (ED) are two most common complic...

Detailed Description

Urinary incontinence and erectile dysfunction (ED) are two most common complications after RP. Despite the advancement of prostate cancer treatment, erectile dysfunction post-prostatectomy remains as ...

Eligibility Criteria

Inclusion

  • Patients who underwent radical prostatectomy (open, laparoscopic or robotic-assisted) with nerve-sparing (unilateral or bilateral).
  • Low / intermediate-risk prostate cancer
  • PSA \< 20 ng/ml
  • Gleason score \< 8
  • Prostate cancer pathological stage \</= T2b
  • Sexually active with IIEF-5 score 3 18, with or without use of erectogenic aid / PDE5i.

Exclusion

  • Tumour upstaging beyond T2b
  • Neurovascular bundle tissues bilaterally in the histopathological report.
  • Scheduled treatment with pelvic radiotherapy and / or androgen deprivation therapy post-RP.
  • Men with ED of neuropathological, endocrine or psychogenic origin.
  • Previous pelvic surgery or radiation therapy.
  • Patients with uncontrolled psychiatric conditions.
  • Patients with major post-operative complications that could impact safety or effectiveness of ESWT.
  • Patients with heart disease - unable to take PDE5i or prohibited from sexual activity.
  • Patients on anticoagulation / antiplatelets except aspirin up to 100mg daily.
  • Inflammation in the shockwave area or having penile pathology such as Peyronie's disease.

Key Trial Info

Start Date :

July 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2025

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT06076850

Start Date

July 1 2023

End Date

June 30 2025

Last Update

October 11 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Sultan Abdul Aziz Shah, Universiti Putra Malaysia (previously known as HPUPM)

Serdang, Selangor, Malaysia, 43400